Technological Achievements

Featured in: Favicon

Articles

Cost-effectiveness of immune checkpoint inhibitors as a first-line therapy for advanced hepatocellular carcinoma: a systematic review - Health Economics Review

Jul 5, 2024 | healtheconomicsreview.biomedcentral.com | Siew Chin |Kunming City |Universiti Sains Malaysia |Technological Achievements |Hongyu Gong |Siew Chin Ong | +6 more

This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement (Supplementary Table 1) [26]. The systematic review was registered on the international prospective register of systematic reviews (PROSPERO) database (CRD42023417391). We searched Scopus, Web of Science, PubMed, Embase, and Cochrane Central databases.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.